4//SEC Filing
LERNER RICHARD A 4
Accession 0001209191-20-028898
CIK 0001567514other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:20 PM ET
Size
12.6 KB
Accession
0001209191-20-028898
Insider Transaction Report
Form 4
LERNER RICHARD A
Director
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$2.74/sh+25,000$68,500→ 97,313 total(indirect: By Trust) - Sale
Common Stock
2020-05-11$20.50/sh−3,500$71,750→ 93,813 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2020-05-11−12,500→ 0 totalExercise: $2.74Exp: 2020-06-10→ Common Stock (12,500 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-05-11−12,500→ 0 totalExercise: $2.74Exp: 2020-12-21→ Common Stock (12,500 underlying)
Holdings
- 11,430
Common Stock
Footnotes (4)
- [F1]Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
- [F2]The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of options.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.51 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]All shares underlying this option have vested.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001316274
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:20 PM ET
- Size
- 12.6 KB